ELAN Q3 2022 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena

ELANElanco Animal Health Incorporated

$12B

Q3 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.0B-9.3% YoY

Gross Profit

$426M41.5% margin

Operating Income

$50M4.9% margin

Net Income

-$65M-6.3% margin

EPS (Diluted)

$-0.13

QoQ Revenue Growth

-12.7%

Cash Flow

Operating Cash Flow

$189M

Free Cash Flow

$143M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$14.9B

Total Liabilities

$8.2B

Stockholders' Equity

$6.7B

Cash & Equivalents

$460M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.0B	$1.1B	-9.3%
Gross Profit	$426M	$488M	-12.7%
Operating Income	$50M	$52M	-3.8%
Net Income	-$65M	-$104M	+37.5%

Revenue Segments

Farm Animal

$545M36%

Pet Health

$471M31%

Cattle

$227M15%

Poultry

$176M12%

Swine

$95M6%

Contract Manufacturing

$12M1%

Geographic Segments

Non-US

$553M54%

UNITED STATES

$475M46%